Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Abroad (travel likely)Recruiting

Conditions

Cardiogenic Shock · Heart Failure · Ambulatory Hemodynamic Monitoring

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads
  • Shashank Sinha, MD MSc

    Principal Investigator

    Inova Fairfax Medical Campus